Key result
Higher baseline LVEF is linked to lower MACE risk in paediatric myocarditis.
Why the study?
Early identification of high-risk paediatric myocarditis patients is essential, but robust prognostic markers are lacking.
Cohort (n=725)
Yes
Odds Ratio: 0.9 (95% CI 0.881–0.917)
p-value: p=<0.01
Reduced LVEF at presentation is a robust, externally validated early risk stratifier for major adverse cardiovascular events during the index hospitalization for paediatric myocarditis.
Supports LVEF assessment for early MACE risk stratification in paediatric myocarditis; extends registry data but leaves open impact on management.
Background and Aims In myocarditis, early identification of high-risk patients is essential, robust prognostic markers are lacking. We aimed to identify early clinical risk stratifier at index hospitalization for major adverse cardiovascular events (MACE). Methods We analysed 725 paediatric patients with possible/definite myocarditis enrolled in the prospective multicentre MYKKE registry (2013–2024). MACE included mechanical circulatory support (MCS), heart transplantation, or death during initial admission. Model-based recursive partitioning (MOB) and bootstrap-based logistic regression with multiple imputation were applied for risk stratifier selection out of 20 baseline variables. The model was externally validated in the Swedish SWEDCON- cohort (n = 243). Discrimination was assessed by the area under the curve (AUC). Results Among 725 patients (median age 14.3 years [IQR 4.0–16.4]; 33% female), 88 (12.2%) experienced MACE (MCS 10.9%, transplantation 4.3%, death 2.2%). MOB identified left ventricular ejection fraction (LVEF) ≤ 39% as the only stable risk stratifier, delineating a “heart failure type” in younger children (1.9 years; LVEF 24%), and a “chest pain type” in adolescents with preserved LVEF (15.6 years; LVEF 59%). LVEF was confirmed as the sole robust risk stratifier (OR per 1% increase: 0.90 ; 95% CI 0.881-0.917; p < 0.01; AUC 0.90, 95% CI 0.896–0.903). In SWEDCON (7.4% MACE), discrimination was maintained (AUC 0.894, 95% CI 0.80–0.991). Conclusion Reduced LVEF at presentation was the only reproducible and externally validated risk stratifier of MACE during index hospitalization. Two age-associated clinical patterns were observed: a high-risk “heart failure type” in younger children and low-risk “chest pain type” in adolescents.
No takes yet. Share an insight, caveat, or question.
Seidel et al. (2026) conducted a cohort in Paediatric myocarditis (n=725). Left ventricular ejection fraction (LVEF) was evaluated on Major adverse cardiovascular events (MACE) including mechanical circulatory support, heart transplantation, or death during initial admission (OR 0.90, 95% CI 0.881-0.917, p=<0.01). Left ventricular ejection fraction at presentation was the sole robust risk stratifier for MACE in paediatric myocarditis (OR 0.90 per 1% increase; 95% CI 0.881-0.917; p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: